Riboflavin Corneal Crosslinking Market to Reach USD 385 Million by...

added blog Other

2026-10-28 12:36:22 -

Riboflavin Corneal Crosslinking Market to Reach USD 385 Million by 2034, Growing at a CAGR of 8.5%

Market Overview The global Riboflavin Corneal Crosslinking Market was valued at USD 185.0 million in 2025 and is estimated to reach USD 200.7 million in 2026. The market is projected to grow to USD 385.0 million by 2034, registering a CAGR of 8.5% during 2026–2034. Riboflavin, also known as vitamin B2, is used in ultraviolet-A (UVA)-activated corneal collagen crosslinking...

0 Comments 0 Shares 79 Views 0 Reviews